James Caggiano
CHIEF EXECUTIVE, DENDREON PHARMACEUTICALS LLC
Commercial-stage biopharma … 1st FDA OK, immunotherapy with drug Provenge, 2010 … prostate cancer … BK, sold to Valeant, 2014, $495M … 2016, sold to China’s Sanpower, $820M … Seal Beach HQ … 200 workers … offices: Seattle; Union City, Ga. … after earlier slots at Dendreon, Allergan, Valeant; rejoined Dendreon … treatment: after cells harvested, processed, must be back into patient, 18 hours … team of 15 monitors delivery 24/7
